» Articles » PMID: 32765211

Aberrant Cerebellar Circuitry in the Spinocerebellar Ataxias

Overview
Journal Front Neurosci
Date 2020 Aug 9
PMID 32765211
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The spinocerebellar ataxias (SCAs) are a heterogeneous group of neurodegenerative diseases that share convergent disease features. A common symptom of these diseases is development of ataxia, involving impaired balance and motor coordination, usually stemming from cerebellar dysfunction and neurodegeneration. For most spinocerebellar ataxias, pathology can be attributed to an underlying gene mutation and the impaired function of the encoded protein through loss or gain-of-function effects. Strikingly, despite vast heterogeneity in the structure and function of disease-causing genes across the SCAs and the cellular processes affected, the downstream effects have considerable overlap, including alterations in cerebellar circuitry. Interestingly, aberrant function and degeneration of Purkinje cells, the major output neuronal population present within the cerebellum, precedes abnormalities in other neuronal populations within many SCAs, suggesting that Purkinje cells have increased vulnerability to cellular perturbations. Factors that are known to contribute to perturbed Purkinje cell function in spinocerebellar ataxias include altered gene expression resulting in altered expression or functionality of proteins and channels that modulate membrane potential, downstream impairments in intracellular calcium homeostasis and changes in glutamatergic input received from synapsing climbing or parallel fibers. This review will explore this enhanced vulnerability and the aberrant cerebellar circuitry linked with it in many forms of SCA. It is critical to understand why Purkinje cells are vulnerable to such insults and what overlapping pathogenic mechanisms are occurring across multiple SCAs, despite different underlying genetic mutations. Enhanced understanding of disease mechanisms will facilitate the development of treatments to prevent or slow progression of the underlying neurodegenerative processes, cerebellar atrophy and ataxic symptoms.

Citing Articles

Genetic modeling of degenerative diseases and mechanisms of neuronal regeneration in the zebrafish cerebellum.

Namikawa K, Pose-Mendez S, Koster R Cell Mol Life Sci. 2024; 82(1):26.

PMID: 39725709 PMC: 11671678. DOI: 10.1007/s00018-024-05538-z.


A dominant negative Kcnd3 F227del mutation in mice causes spinocerebellar ataxia type 22 (SCA22) by impairing ER and Golgi functioning.

Hung H, Lin J, Teng Y, Kao C, Wang P, Soong B J Pathol. 2024; 265(1):57-68.

PMID: 39562497 PMC: 11638663. DOI: 10.1002/path.6368.


Polyserine peptides are toxic and exacerbate tau pathology in mice.

Van Alstyne M, Nguyen V, Hoeffer C, Parker R bioRxiv. 2024; .

PMID: 39416198 PMC: 11482949. DOI: 10.1101/2024.10.10.616100.


Tracking longitudinal thalamic volume changes during early stages of SCA1 and SCA2.

Grisoli M, Nigri A, Medina Carrion J, Palermo S, Demichelis G, Giacosa C Radiol Med. 2024; 129(8):1215-1223.

PMID: 38954239 PMC: 11322486. DOI: 10.1007/s11547-024-01839-2.


Proteomics and lipidomic analysis reveal dysregulated pathways associated with loss of sacsin.

Galatolo D, Rocchiccioli S, Di Giorgi N, Canto F, Signore G, Morani F Front Neurosci. 2024; 18:1375299.

PMID: 38911600 PMC: 11191878. DOI: 10.3389/fnins.2024.1375299.


References
1.
Kimura M, Yabe I, Hama Y, Eguchi K, Ura S, Tsuzaka K . SCA42 mutation analysis in a case series of Japanese patients with spinocerebellar ataxia. J Hum Genet. 2017; 62(9):857-859. DOI: 10.1038/jhg.2017.51. View

2.
Bavassano C, Eigentler A, Stanika R, Obermair G, Boesch S, Dechant G . Bicistronic CACNA1A Gene Expression in Neurons Derived from Spinocerebellar Ataxia Type 6 Patient-Induced Pluripotent Stem Cells. Stem Cells Dev. 2017; 26(22):1612-1625. PMC: 5684673. DOI: 10.1089/scd.2017.0085. View

3.
Depondt C, Donatello S, Rai M, Wang F, Manto M, Simonis N . MME mutation in dominant spinocerebellar ataxia with neuropathy (SCA43). Neurol Genet. 2016; 2(5):e94. PMC: 4991603. DOI: 10.1212/NXG.0000000000000094. View

4.
Lin P, Zhang D, Xu G, Yan C . Identification of IFRD1 variant in a Han Chinese family with autosomal dominant hereditary spastic paraplegia associated with peripheral neuropathy and ataxia. J Hum Genet. 2018; 63(4):521-524. DOI: 10.1038/s10038-017-0394-7. View

5.
Matsuyama Z, Wakamori M, Mori Y, Kawakami H, Nakamura S, Imoto K . Direct alteration of the P/Q-type Ca2+ channel property by polyglutamine expansion in spinocerebellar ataxia 6. J Neurosci. 1999; 19(12):RC14. PMC: 6782654. View